心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 临床实践建议：围术期心脏骤停的管理

2021-07-29 围术期心脏骤停工作小组 Crit Care

围术期心脏骤停

2021年7月，围术期心脏骤停（PERIOPCA）工作小组发布了围术期心脏骤停的管理建议。围术期心脏骤停是一种罕见的并发症，本文主要针对围术期心脏骤停的管理提出了22个PICO问题以及相应的管理建议。

中文标题：

2021 临床实践建议：围术期心脏骤停的管理

英文标题：

Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium

发布机构：

围术期心脏骤停工作小组

发布日期：

2021-07-29

简要介绍：

2021年7月，围术期心脏骤停（PERIOPCA）工作小组发布了围术期心脏骤停的管理建议。围术期心脏骤停是一种罕见的并发症，本文主要针对围术期心脏骤停的管理提出了22个PICO问题以及相应的管理建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 临床实践建议：围术期心脏骤停的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=10aa71c0022052d7, title=2021 临床实践建议：围术期心脏骤停的管理, enTitle=Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium, guiderFrom=Crit Care, authorId=0, author=, summary=2021年7月，围术期心脏骤停（PERIOPCA）工作小组发布了围术期心脏骤停的管理建议。围术期心脏骤停是一种罕见的并发症，本文主要针对围术期心脏骤停的管理提出了22个PICO问题以及相应的管理建议。, cover=https://img.medsci.cn/20211214/1639463852251_1614372.png, journalId=0, articlesId=null, associationId=2007, associationName=围术期心脏骤停工作小组, associationIntro=围术期心脏骤停工作小组, copyright=0, guiderPublishedTime=Thu Jul 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年7月，围术期心脏骤停（PERIOPCA）工作小组发布了围术期心脏骤停的管理建议。围术期心脏骤停是一种罕见的并发症，本文主要针对围术期心脏骤停的管理提出了22个PICO问题以及相应的管理建议。</span></p>, tagList=[TagDto(tagId=115971, tagName=围术期心脏骤停)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=885, guiderKeyword=心脏骤停, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2561, appHits=106, showAppHits=0, pcHits=1324, showPcHits=2455, likes=0, shares=7, comments=9, approvalStatus=1, publishedTime=Thu Oct 14 22:21:31 CST 2021, publishedTimeString=2021-07-29, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Thu Oct 14 22:21:00 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 19:28:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 临床实践建议：围术期心脏骤停的管理.pdf)])
2021 临床实践建议：围术期心脏骤停的管理.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196306, encodeId=6f66119630606, content=学习学习……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b5d3045764, createdName=729787690, createdTime=Wed Feb 23 08:43:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061659, encodeId=ae2a1061659e1, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Tue Oct 19 00:44:15 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060620, encodeId=aa5310606202d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88bb5555005, createdName=张啟明, createdTime=Fri Oct 15 07:52:36 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060615, encodeId=f92f10606154c, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Fri Oct 15 07:34:09 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060609, encodeId=8998106060933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:13 CST 2021, time=2021-10-15, status=1, ipAttribution=)]
    2022-02-23 729787690

    学习学习……

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196306, encodeId=6f66119630606, content=学习学习……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b5d3045764, createdName=729787690, createdTime=Wed Feb 23 08:43:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061659, encodeId=ae2a1061659e1, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Tue Oct 19 00:44:15 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060620, encodeId=aa5310606202d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88bb5555005, createdName=张啟明, createdTime=Fri Oct 15 07:52:36 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060615, encodeId=f92f10606154c, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Fri Oct 15 07:34:09 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060609, encodeId=8998106060933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:13 CST 2021, time=2021-10-15, status=1, ipAttribution=)]
    2021-10-19 Doctoryangbai

    获益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196306, encodeId=6f66119630606, content=学习学习……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b5d3045764, createdName=729787690, createdTime=Wed Feb 23 08:43:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061659, encodeId=ae2a1061659e1, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Tue Oct 19 00:44:15 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060620, encodeId=aa5310606202d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88bb5555005, createdName=张啟明, createdTime=Fri Oct 15 07:52:36 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060615, encodeId=f92f10606154c, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Fri Oct 15 07:34:09 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060609, encodeId=8998106060933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:13 CST 2021, time=2021-10-15, status=1, ipAttribution=)]
    2021-10-15 张啟明

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1196306, encodeId=6f66119630606, content=学习学习……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b5d3045764, createdName=729787690, createdTime=Wed Feb 23 08:43:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061659, encodeId=ae2a1061659e1, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Tue Oct 19 00:44:15 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060620, encodeId=aa5310606202d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88bb5555005, createdName=张啟明, createdTime=Fri Oct 15 07:52:36 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060615, encodeId=f92f10606154c, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Fri Oct 15 07:34:09 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060609, encodeId=8998106060933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:13 CST 2021, time=2021-10-15, status=1, ipAttribution=)]
    2021-10-15 ms3000001592172450

    受益匪浅！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1196306, encodeId=6f66119630606, content=学习学习……, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b5d3045764, createdName=729787690, createdTime=Wed Feb 23 08:43:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061659, encodeId=ae2a1061659e1, content=获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Tue Oct 19 00:44:15 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060620, encodeId=aa5310606202d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88bb5555005, createdName=张啟明, createdTime=Fri Oct 15 07:52:36 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060615, encodeId=f92f10606154c, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Fri Oct 15 07:34:09 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060609, encodeId=8998106060933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:13 CST 2021, time=2021-10-15, status=1, ipAttribution=)]
    2021-10-15 微探

    学习学习

    0

拓展阅读

2016 心脏骤停后目标温度管理专家共识

国内急诊/重症相关专家小组（统称） · 2016-08-04

2015 AHA科学声明：妊娠期心脏骤停

美国心脏协会(AHA,American Heart Association) · 2015-10-06

2015 ILCOR/AHA建议声明：心脏骤停后体温管理

美国心脏协会(AHA,American Heart Association) · 2015-10-04

美国心脏学会关于孕妇心脏骤停的科学声明

暂未更新 · 2017-02-05

2018 AHA科学声明：复苏教育-改善心脏骤停结局的教育策略

美国心脏协会(AHA,American Heart Association) · 2018-06-21

2018 ERC复苏指南：心脏骤停抗心律失常药物的应用（更新版）

欧洲复苏委员会(ERC,European Resuscitation Council) · 2018-11-26